Cliff Asness's OPRX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 214,954 shares of OptimizeRx Corporation (OPRX) worth $1.35 M, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in OPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 200,440 shares. Largest reduction occurred in Q4 2019, reducing 14,017 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's OptimizeRx Corporation (OPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly OptimizeRx Corporation (OPRX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +200,440 | Add 1381.01% | 214,954 | $6.28 |
| Q4 2025 | +2,256 | Add 18.40% | 14,514 | $12.26 |
| Q3 2025 | +12,258 | New Buy | 12,258 | $20.50 |
| Q1 2024 | -11,172 | Sold Out | 0 | $0.00 |
| Q4 2023 | -1,183 | Reduce 9.58% | 11,172 | $14.31 |
| Q3 2023 | +12,355 | New Buy | 12,355 | $7.78 |
| Q4 2022 | -13,215 | Sold Out | 0 | $0.00 |
| Q3 2022 | +13,215 | New Buy | 13,215 | $14.83 |
| Q2 2022 | -8,508 | Sold Out | 0 | $0.00 |
| Q1 2022 | +1,753 | Add 25.95% | 8,508 | $37.73 |
| Q4 2021 | -4,299 | Reduce 38.89% | 6,755 | $62.18 |
| Q3 2021 | +6,701 | Add 153.94% | 11,054 | $85.58 |
| Q2 2021 | -382 | Reduce 8.07% | 4,353 | $61.80 |
| Q1 2021 | +4,735 | New Buy | 4,735 | $48.79 |
| Q4 2019 | -14,017 | Sold Out | 0 | $0.00 |
| Q3 2019 | +14,017 | New Buy | 14,017 | $14.48 |
Cliff Asness's OptimizeRx Corporation Investment FAQs
Cliff Asness first purchased OptimizeRx Corporation (OPRX) in Q3 2019, acquiring 14,017 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held OptimizeRx Corporation (OPRX) for 16 quarters since Q3 2019.
Cliff Asness's largest addition to OptimizeRx Corporation (OPRX) was in Q1 2026, adding 214,954 shares worth $1.35 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 214,954 shares of OptimizeRx Corporation (OPRX), valued at approximately $1.35 M.
As of the Q1 2026 filing, OptimizeRx Corporation (OPRX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in OptimizeRx Corporation (OPRX) was 214,954 shares, as reported at the end of Q1 2026.